Health

Results: 4009-4020 of 8221

Hansa Biopharma announces positive full results from 15-HMedIdeS-09 Phase 2 study and comparative analysis of imlifidase in patients with Guillain-Barré Syndrome

PR Newswire associated0

Jazz Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

PR Newswire associated0

Zentiva hosted the "European Health Check":

YPrime Commits to United Nations Global Compact, Pledging to Align its Sustainable Business Practices with UN Goals

Merck scientist working in company's Burlington, MA, USA cell culture facility (Photo: Business Wire)

Merck to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio

Tiziana Life Sciences Announces First Patient with Moderate Alzheimer’s Disease Dosed with Intranasal Foralumab

Implantica deepens market penetration in Italy with the addition of the ninth RefluxStop™ Center of Excellence and several lined up to start near-term

Orexo enters into collaboration with Abera to develop nasal powder vaccines based on the AmorphOX technology

PR Newswire associated0

Jazz Pharmaceuticals Announces CEO Succession Plan

(Photo: Business Wire)

Carestream Secures Crucial Business Partner Agreement in Algeria

DID YOU HAVE A HIP, KNEE, OR OTHER JOINT REPLACEMENT?

PR Newswire associated0

Menarini Group announces Positive Topline Data from Pivotal Phase 3 BROADWAY & TANDEM Clinical Trials Evaluating Obicetrapib and the Fixed-Dose Combination Obicetrapib with Ezetimibe 10 mg